000 01421 a2200409 4500
005 20250513111115.0
264 0 _c19970408
008 199704s 0 0 eng d
022 _a0149-2918
024 7 _a10.1016/s0149-2918(96)80062-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerber, A C
245 0 0 _aUse of Broncho-Vaxom in private practice: phase IV trial in 587 children.
_h[electronic resource]
260 _bClinical therapeutics
_c
300 _a1068-79 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase IV; Comparative Study; Controlled Clinical Trial; Journal Article; Multicenter Study
650 0 4 _aAcute Disease
650 0 4 _aAdjuvants, Immunologic
_xadministration & dosage
650 0 4 _aAdministration, Oral
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aBacteria
650 0 4 _aCell Extracts
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPrivate Practice
650 0 4 _aRecurrence
650 0 4 _aRespiratory Tract Infections
_xdrug therapy
650 0 4 _aSafety
650 0 4 _aTreatment Outcome
700 1 _aDel-Rio-Navarro, B E
773 0 _tClinical therapeutics
_gvol. 18
_gno. 6
_gp. 1068-79
856 4 0 _uhttps://doi.org/10.1016/s0149-2918(96)80062-2
_zAvailable from publisher's website
999 _c8992961
_d8992961